Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening.
about
My approach to the treatment of sclerodermaScleroderma lung diseaseUndiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients.Current therapies for the treatment of systemic sclerosis-related pulmonary arterial hypertension: efficacy and safety.Current and future direction in the management of scleroderma.Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis.Systemic sclerosis-associated pulmonary arterial hypertension.
P2860
Q24618843-18D4E89B-9846-4F7D-A180-13F47B5B538FQ33919119-A062855E-1154-49C9-8E22-ED60EC3D405DQ37605794-FF541AE4-3BF1-4624-90CE-1CEE7E42130BQ38175430-EBFE6A9E-C6EA-4C11-B6AD-AA5B4F206E52Q38823948-92EA567E-5F99-43DC-9BB7-0795C0F12875Q50859476-2693E43C-372A-4A1A-B02E-DF1E329AC95FQ55309547-17827045-2C35-49E6-BB6C-382B01546D66
P2860
Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Risk factors associated with p ...... nd implications for screening.
@en
Risk factors associated with p ...... nd implications for screening.
@nl
type
label
Risk factors associated with p ...... nd implications for screening.
@en
Risk factors associated with p ...... nd implications for screening.
@nl
prefLabel
Risk factors associated with p ...... nd implications for screening.
@en
Risk factors associated with p ...... nd implications for screening.
@nl
P1476
Risk factors associated with p ...... and implications for screening
@en
P2093
C P Denton
P304
P356
10.1183/09059180.00006111
P577
2011-12-01T00:00:00Z